Sofinnova Partners

AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer

Sofinnova Partners: AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer

Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases

Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer

AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors

Sofinnova Partners: SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States

Gradient Denervation Technologies Raises €3.5M in Seed Funding with Sofinnova Partners

Sofinnova Partners: MastOR annonce un financement d’amorçage auprès de Sofinnova Partners pour développer sa plateforme d’assistance chirurgicale

MastOR Secures Seed Funding from Sofinnova Partners to Develop its Laparoscopy Assistance Platform